683 Capital Management’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,355	Closed	-$150K	–	232
2023 Q1	$150K	Hold	10,355	–	–	0.01%	176
2022 Q4	$140K	Buy	+10,355	New	+$140K	0.01%	214